Literature DB >> 23365495

An overview on the development of newcastle disease virus as an anti-cancer therapy.

Abdul Rahman Omar, Aini Ideris, Abdul Manaf Ali, Fauziah Othman, Khatijah Yusoff, Jafri Malin Abdullah, Haryati Shila Mohamad Wali, Madihah Zawawi, Narayani Meyyappan.   

Abstract

Newcastle disease virus (NDV) is one of the most economically important avian virus which affects the poultry industry worldwide. Although NDV is being very actively studied in Malaysia, there are still no studies on its potential as an anticancer agent, a new approach to treating cancer known as virotherapy. Currently, a collaborative research is being undertaken between Universiti Putra Malaysia (UPM), Universiti Sains Malaysia (USM) and Majlis Kanser Nasional (MAKNA) in characterising various local NDV isolates as anticancer agent. This paper describes an overview of the research that have been carried out worldwide in the use of NDV for cancer treatment and also some of our findings in characterising local NDVs with oncolytic properties.

Entities:  

Keywords:  Newcastle disease virus; anticancer agent; apoptosis

Year:  2003        PMID: 23365495      PMCID: PMC3557104     

Source DB:  PubMed          Journal:  Malays J Med Sci        ISSN: 1394-195X


  50 in total

1.  Performance of an RT-nested PCR ELISA for detection of Newcastle disease virus.

Authors:  C L Kho; M L Mohd-Azmi; S S Arshad; K Yusoff
Journal:  J Virol Methods       Date:  2000-04       Impact factor: 2.014

2.  Use of Newcastle disease virus vaccine (MTH-68/H) in a patient with high-grade glioblastoma.

Authors:  L K Csatary; T Bakács
Journal:  JAMA       Date:  1999-05-05       Impact factor: 56.272

3.  NEWCASTLE DISEASE VIRUS AS AN ANTINEOPLASTIC AGENT.

Authors:  W A CASSEL; R E GARRETT
Journal:  Cancer       Date:  1965-07       Impact factor: 6.860

4.  Propagation of Newcastle disease virus in Ehrlich ascites cells in vitro and in vivo.

Authors:  A D FLANAGAN; R LOVE; W TESAR
Journal:  Proc Soc Exp Biol Med       Date:  1955-10

5.  A new host-virus system.

Authors:  W W ACKERMANN; H KURTZ
Journal:  Proc Soc Exp Biol Med       Date:  1952-11

6.  Newcastle disease virus activates macrophages for anti-tumor activity.

Authors:  V Schirrmacher; L Bai; V Umansky; L Yu; Y Xing; Z Qian
Journal:  Int J Oncol       Date:  2000-02       Impact factor: 5.650

Review 7.  Newcastle disease virus (NDV): brief history of its oncolytic strains.

Authors:  J G Sinkovics; J C Horvath
Journal:  J Clin Virol       Date:  2000-02       Impact factor: 3.168

8.  Beneficial treatment of patients with advanced cancer using a Newcastle disease virus vaccine (MTH-68/H).

Authors:  L K Csatary; R W Moss; J Beuth; B Töröcsik; J Szeberenyi; T Bakacs
Journal:  Anticancer Res       Date:  1999 Jan-Feb       Impact factor: 2.480

9.  Generation of recombinant lentogenic Newcastle disease virus from cDNA.

Authors:  Angela Römer-Oberdörfer; Egbert Mundt; Teshome Mebatsion; Ursula J Buchholz; Thomas C Mettenleiter
Journal:  J Gen Virol       Date:  1999-11       Impact factor: 3.891

10.  Newcastle disease virus: macromolecules and opportunities.

Authors:  K Yusoff; W S Tan
Journal:  Avian Pathol       Date:  2001-10       Impact factor: 3.378

View more
  8 in total

1.  Cytolytic effects and apoptosis induction of Newcastle disease virus strain AF2240 on anaplastic astrocytoma brain tumor cell line.

Authors:  Rola Ali; Aied M Alabsi; Abdul Manaf Ali; Aini Ideris; Abdul Rahman Omar; Khatijah Yusoff; Riyadh Saif-Ali
Journal:  Neurochem Res       Date:  2011-06-14       Impact factor: 3.996

Review 2.  Safety and clinical usage of newcastle disease virus in cancer therapy.

Authors:  Han Yuen Lam; Swee Keong Yeap; Mehdi R Pirozyan; Abdul Rahman Omar; Khatijah Yusoff; Abd Aziz Suraini; Noorjahan Banu Alitheen
Journal:  J Biomed Biotechnol       Date:  2011-10-26

3.  Effects of newcastle disease virus strains AF2240 and V4-UPM on cytolysis and apoptosis of leukemia cell lines.

Authors:  Aied M Alabsi; Siti Aishah Abu Bakar; Rola Ali; Abdul Rahman Omar; Mohd Hair Bejo; Aini Ideris; Abdul Manaf Ali
Journal:  Int J Mol Sci       Date:  2011-11-30       Impact factor: 5.923

Review 4.  Replication-Competent Viruses as Cancer Immunotherapeutics: Emerging Clinical Data.

Authors:  Dmitriy Zamarin; Sari Pesonen
Journal:  Hum Gene Ther       Date:  2015-08       Impact factor: 5.695

5.  Evaluation of Ultra-Microscopic Changes and Proliferation of Apoptotic Glioblastoma Multiforme Cells Induced by Velogenic Strain of Newcastle Disease Virus AF2240

Authors:  Rola Ali- Saeed; Aied M Alabsi; Aini Ideris; Abdul Rahman Omar; Khatijah Yusoff; Abdul Manaf Ali
Journal:  Asian Pac J Cancer Prev       Date:  2019-03-26

Review 6.  Advances in the Study of Antitumour Immunotherapy for Newcastle Disease Virus.

Authors:  Qiuxing Meng; Jian He; Liping Zhong; Yongxiang Zhao
Journal:  Int J Med Sci       Date:  2021-03-30       Impact factor: 3.738

7.  Caspase Dependent and Independent Anti-hematological Malignancy Activity of AMHA1 Attenuated Newcastle Disease Virus.

Authors:  Mohammed S Mohammed; Maha F Al-Taee; Ahmed Majeed Al-Shammari
Journal:  Int J Mol Cell Med       Date:  2019

8.  Liver Pathology in Rats Treated with Newcastle Disease Virus Strains AF2240 and V4-UPM.

Authors:  Rowa Mohammed Assayaghi; Aied Mohammed Alabsi; Gumballi Swethadri; Abdul Manaf Ali
Journal:  Asian Pac J Cancer Prev       Date:  2019-10-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.